EASL
New Analyses Evaluate Resmetirom’s Effects on MASH and Fibrosis
Patients with MASH and F2 or F3 fibrosis treated with resmetirom had improvements in both fibrosis and MASH over 52 ...
JANUARY 13, 2025
Societies Change Term for Fatty Liver To Focus on Steatosis
After years of discussion and review, an international working group has announced recently that they will refer to ...
AUGUST 28, 2023
Expert Picks From EASL 2022: Liver Disease
Seven noteworthy abstracts from EASL 2022 on topics including nonalcoholic steatohepatitis-related cirrhosis, ...
NOVEMBER 8, 2022
Survey Documents Pandemic’s Toll On Liver Cancer Screening
Clinicians and patients faced significant disruption in liver cancer screening during the early COVID-19 pandemic, ...
JUNE 17, 2021
EASL at a Glance
The European Association for the Study of the Liver held its annual International Liver Congress in April, in ...
MAY 23, 2018
